Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Clinical Genitourinary Cancer|June 6, 2024
Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on <sup>18</sup>F-DCFPyL PET/CTMiles Hsu, Xinhe Shan, Rebecca Zhang, et al.
The Lancet. Oncology|April 14, 2025
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 studyRamaprasad Srinivasan, Othon Iliopoulos, Kathryn E Beckermann, et al.
Cancer Cell|September 11, 2020
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 TrialPadmanee Sharma, Russell K Pachynski, Vivek Narayan, et al.
Cardio-Oncology (London, England)|March 16, 2025
Principles of optimal multidisciplinary management of prostate cancer in clinical practiceFilipe Cirne, Michiel Sedelaar, Vivek Narayan, et al.
The Oncologist|May 4, 2026
Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castrate-resistant prostate cancer: a pooled analysisAbhiraj Saxena, Marc Yorker, Nicholas A Zorko, et al.
Journal of the American College of Cardiology|July 8, 2017
Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast CancerBrian S Finkelman, Mary Putt, Teresa Wang, et al.
Clinical Genitourinary Cancer|May 16, 2023
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional StudyCorbin J Eule, Junxiao Hu, Sulaiman Al-Saad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2017
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell CarcinomaVivek Narayan, Stephen Keefe, Naomi Haas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 StudyTobias Else, Eric Jonasch, Othon Iliopoulos, et al.
JACC. Basic to Translational Science|February 7, 2022
Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without TrastuzumabElizabeth W Thompson, Biniyam G Demissei, Amanda M Smith, et al.
Pageof 13